en Nature Reviews Drug Discovery

*Nature Reviews Drug Discovery*
Discipline	Pharmacology, Biotechnology
Language	English
Edited by	Peter Kirkpatrick
Publication details
History	2002–present
Publisher	Nature Portfolio
Frequency	Monthly
Impact factor	120.1 (2022)
Standard abbreviations;
ISO 4	Nat. Rev. Drug Discov.
Indexing;
CODEN	NRDDAG
ISSN	1474-1776 (print); 1474-1784 (web);
LCCN	2002243044
OCLC no.	427380493
Links
	Journal homepage; Online access; Online archive;

Nature Reviews Drug Discovery is a monthly peer-reviewed review journal published by Nature Portfolio. It was established in 2002^[1] and covers drug discovery and development. The editor-in-chief is Peter Kirkpatrick.^[2] According to the Journal Citation Reports, the journal has a 2021 impact factor of 112.288, ranking it 1st out of 158 journals in the category "Biotechnology & Applied Microbiology"^[3] and 1st out of 279 journals in the category "Pharmacology & Pharmacy".^[4]

Reviews are commissioned to specialists and supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal publishes analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces.^[5]